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A B S T R A C T
Discharges of care, analyses and research activities from hospital wards are the source of the specificity of
hospital effluents because they contain, among others, drug residues, detergents and disinfectants. Even if
hospitals represent a small fraction of the total drug load discharged into the environment, below 10% for drugs,
the characterization of this specific effluent shows that global pollution is 2–3 times more concentrated than
urban wastewater. Moreover this ratio increases to 150 times for some micropollutants. Activated sludge ac-
climation in 2 membrane bioreactor (MBR) configurations (external and external submerged) to effluents from
an oncological ward will be studied monitoring the performances on conventional pollution parameters (che-
mical oxygen demand, ammonium, total suspended solids etc.). The performances of drug degradation are
compared with the data of the literature and with degradation tests in batch reactor with no acclimated biomass
from a municipal wastewater treatment plant. The results are achieved for effluents with a high concentration of
drug molecules, up to 6.82 mg L−1 for ifosfamide. The treatment allows the development of enhanced pur-
ification efficiencies on drug molecules and confirms the choice of a MBR process to treat this effluent, although
the simultaneous presence of the various compounds leads to a complex biological response. Indeed, 5-FU was
eliminated almost systematically over 90%. Sulfamethoxazole and codeine can be significantly eliminated
biologically, respectively to 79 and 95%. IF and CP removal in the reactor appeared more moderate since it does
not exceed 40% but membrane fouling led to higher removals of both molecules.
1. Introduction
The problem of drug residues in the environment is global and af-
fects all segments as pharmaceuticals have been detected in surface
water and groundwater, wastewater, soil and sewage sludge [20,7,47].
The presence of drug residues in the environment and the subsequent
transmission are considered as a negligible risk for human health [12].
However, these studies have some limitations since the therapeutic dose
does not play the role of toxicological reference value and the effects of
mixtures are not considered. In view of the reality of environmental
contamination and the first proven effects it is necessary to develop
innovative treatment methods in order to propose effective solutions
[39]. However, the very important flow of wastewater to be treated
represents a major brake to the optimization of the existing Waste
Water Treatment Plant (WWTP) to address this pollution and to spread
with an energy-efficient aspect of advanced technologies [39]. On the
contrary, the directly on-site treatment of effluents potentially heavily
loaded with drug residues could represent a sensible compromise. The
implementation of reduced treatment units would indeed limit invest-
ment costs and treat effluents more concentrated in drug residues.
Hospital WasteWaters (HWW) come from all the hospital activities and
can be qualitatively divided into three categories [15,17]: (i) domestic
discharges, (ii) industrial discharges (laundry, boiler rooms…) (iii)
discharges of care, analyses and research activities. The latter category
is the source of the specificity of hospital effluents because they contain,
among others, drug residues, detergents and disinfectants. Biochemical
characterization [61] shows that HWW conventional pollution is 2–3
times more concentrated than Urban Waste Water (UWW) and the
variability of concentrations is very important according to hospitals.
The patient related pollution is therefore about twice more than the
inhabitant equivalent pollution. Microbiological characterization
[18,27] shows that bacteria in HWW are more resistant to antibiotics
than those in UWW. Micropollutant pollution average concentrations in
HWW are from 2 to 150 times higher than in UWW depending on mi-
cropollutants [62]. The highest ratios primarily involve antibiotics and
analgesics. Orias and Perrodin [45] point out their great complexity
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with significant qualitative and quantitative changes indicating that the
HWW ecotoxicity strongly depends on the individual case. Hospitals
represent a small fraction of the total drug load, below 10% for most
drugs and even less than 3% for some of them, whereas they are gen-
erally considered as a strategic objective to reduce emissions
[62,52,39]. However, the contribution of hospitals in UWW varies
considerably according to drugs. [62] note that between 16 and 67% of
12 analyzed drugs out of 73 in UWW come from HWW. Santos et al.
[52] indicate in their study that analgesics, antibiotics and non-ster-
oidal anti-inflammatory drugs are the 3 major classes brought by hos-
pitals in UWW with a rate of up to 50%.
Some activities of hospitals produce very specific pollutants that
could be interesting to treat directly by implementing small treatment
units directly on-site [37,28,58,69,33,3]. [38] Orias and Perrodin [45]
also note that little attention was paid so far to antineoplastic drugs
during studies about HWW ecotoxicological risks despite “highest
concentration measured in waste water/predicted non-effect con-
centration” high ratios (244,000 for fluorouracil).
The presence of drug residues and their metabolites in the en-
vironment involves that they are not completely eliminated by con-
ventional wastewater treatment plants (WWTP) with activated sludge.
The sludge age appears to be the key parameter to eliminate micro-
pollutants by activated sludge processes [8,43]. The almost total bio-
mass retention in the membrane bioreactor (MBR) process helps to
work on a sludge age much higher than in WWTPs with conventional
activated sludge. Sipma et al [55] compared the performances of con-
ventional WWTPs with the performances of membrane bioreactors:
only three molecules (solatol, famotidine, hydrochlorotiazide) out of
the 30 selected drugs were better eliminated by conventional WWTPs
than by MBRs. The reduction of the 27 other molecules was either si-
milar or better by MBR, although it should be noted that some mole-
cules remain poorly removed. For poorly biodegradable, polar and
persistent micropollutants such as most of the pharmaceutical mole-
cules, several studies indicate that better eliminations are obtained with
MBR [13,4,49,50,32].
It is noteworthy that for identical Sludge Residence Time (SRT) si-
milar reductions were achieved by MBR and conventional WWTPs on
various micropollutants confirming the major role of SRT in the re-
duction of micropollutants Clara et al., 2004. Therefore, the major
advantage of MBR seems to be the capability to define SRT in-
dependently from Hydraulic Residence Time (HRT). Tambosi et al. [59]
confirmed the role of SRT obtaining a better removal of 6 pharma-
ceutical molecules by increasing the SRT from 15 to 30 days in a MBR.
As a consequence, a high SRT maintains a metabolic potential when a
particular substrate is no longer in the effluent. MBR thus has a
“memory effect” and is therefore more flexible during important fluc-
tuations in concentrations [13].
Few studies have been devoted to the treatment of effluents from a
specific hospital department by MBR. In addition, most of the studies on
specific anticancer drugs have been carried out with synthetic effluents
[14,54] composed of few pharmaceuticals. The originality of this study
is to test the treatment feasibility of a real effluent directly on site of an
oncological ward by MBR. The biomass acclimation to effluents from a
department of oncology is thus studied following the MBR
performances on conventional pollution parameters (COD, SOUR,
Ammonium, etc.) as well as the evolution of Total Suspended Solids
(TSS) in the bioreactor. The acclimation to oncological ward effluent
will be compared for two different MBR configurations: external
membrane (eMBR) and external submerged membranes (sMBRe). The
results are achieved for effluents with very heavy drug concentrations.
2. Materials & methods
2.1. Compounds, follow-up and analysis
The 3 most consumed anticancer drugs in the unit of the department
of oncology of the hospital La Timone (Marseille, France) belong to the
7 anticancer treatments listed by the AFFSA (French Food Safety
Agency): ifosfamide (IF), fluorouracile (5-FU), cyclophosphamide (CP).
The codeine painkiller (CD) and the sulfamethoxazole antibiotic (SM)
were added to the list of medicines taken for the project. According to
their physical and chemical properties the major anticancer drugs seem
mostly persistent with a high mobility in water [33,68]. This is true for
5-FU, CP and IF but also for CD and SM. The very low values of the
water-octanol partition coefficient Kow of the 5 selected drugs indicate
that these molecules are slightly hydrophobic and strongly polar. The
fluorouracil analyses are carried out in the laboratory of pharmacology
and toxic kinetics from the hospital la Timone in Marseille (France).
The cyclophosphamide, ifosfamide, codeine, and sulfamethoxazole
analyses were conducted by the Ianesco laboratory (Institut d’Analyses
et d’Essais en Chimie de l’Ouest) from Poitiers. The protocol for dosing
5-FU in blood plasma was successfully used for dosing in hospital ef-
fluents and treated waters. 5-FU analysis is performed via HPLC-UV.
The quantification limit is 5 μg L−1. The four other molecules i.e. cy-
clophosphamide, ifosfamide, sulfamethoxazole, and codeine are ana-
lyzed simultaneously via liquid chromatography together with a mass
spectrometry (LC/MS-MS). The quantification limit of the analysis is
2.5 μg L−1. Raw waters are settled then filtered on a filter with a por-
osity of 0.45 μm before analysis. The elimination of the coarser solids is
not a priori a problem of underestimation of the concentration of drugs
in HWW since the selected drugs are excreted only through urine and
are hydrophilic thereby neglecting the sorption on the TSS of HWW.
2.2. Hospital wastewaters
The studied effluents come from oncology ward at the hospital La
Timone (Marseille, France). The pipe collects wastewater (sink, shower,
toilets) of 6 rooms without being diluted by the other activities of the
ward. Oncological ward wastewater (HWW) is batch sampled and
gathered in a buffer vessel. Pretreatments consist of a saniflo macerator
system (Plus Silence, SFA, France) and a grid with a 0.5 mm cutoff. The
sampling is performed in the morning in order to have an effluent
loaded enough to ensure a minimum food to microorganism ratio (F/M)
of 0.07 kgCOD kgVSS−1 d−1 corresponding to the operating boundary
conditions chosen regularly for urban effluents [23]. The related F/M
ratio always lies between 0.07 and 0.14 kgCOD kgVSS−1 d−1. The BOD5/
COD ratio shows that the effluent is biodegradable because it is rela-
tively steady between 29 and 48%. These 160 days long campaign has
Nomenclature
List of symbols
HWW hospital wastewater
MWW municipal wastewater
COD chemical oxygen demand
CODS supernatant chemical oxygen demand
CODP Permeate chemical oxygen demand
MLVSS mixed liquor volatile suspended solids
F/M food to microorganisms ratio
TSS total Suspended Solids
eMBR external membrane bioreactor
sMBRe external submerged membrane bioreactor
WWTP wastewater treatment plant
RR retention rate
MIC minimum Inhibitory Concentration
MWCO molecular weight cut off
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two distinct phases because it was decided to co-supply the eMBR with
a synthetic substrate at the 97th operating day. The evolutions of
carbon pollution (COD) and nitrogen pollution (N-NH4+ ) of HWW
during the first experimental campaign have fluctuated considerably
(Fig. 1).
3 working conditions can be considered:
• 0 to 40th day: HWW sampling between 8:00 and 9:30 am;
• 40th to 97th day: HWW sampling during the night to avoid dilution
via shower waters;
• 97th to 160th day: co-supply with HWW and a synthetic substrate to
help acclimation.
On the 40th day, the change of sampling method led to an effluent
more loaded in ammonium. On the 97th day the synthetic substrate
brought a relative stabilization in COD and N-NH4+ concentrations.
Despite the standardization of the sampling method from the 40th day,
important fluctuations in COD and N-NH4+ concentrations have been
identified, which may indicate a certain heterogeneity in the activity of
Oncology ward. The composition of the synthetic substrate to dilute the
specific pollution load of the HWW from the 97th day has been de-
termined from the average COD (800 mg L−1) and N – NH4+
(31 mg L−1) concentrations measured during the period from the 40th
to the 97th day (Table 1). Concentrations in mineral salts are de-
termined by the literature [26,2]. The C/N/P ratio of the synthetic ef-
fluent is 100/4/2 with C corresponding to organic carbon. In this
synthetic wastewater the concentration of C6H1206, (NH4)2SO4, MgSO4,
KH2PO4 and CaCL2 are respectively 800; 146,7; 38,1; 76,2 and
7,6 mg L−1. On the 40th day, the change in the sampling method led to
harmonize the supply C/N ratio reasonably between 15 and 50. The
synthetic substrate added on the 97th day has increased this stabiliza-
tion around 25 and then allows the compensation for the continuous
fluctuations of the HWW C/N ratio.
2.3. Membrane bioreactor
A pilot scale membrane bioreactor was dimensioned, built and im-
plemented nearby in the oncology ward at the hospital La Timone
(Marseille, France) (Fig. 2). The pilot MBR dimensioning was based on
a permeate flow rate included between 1 and 2 L h−1. The pilot allows
an easy change of configuration from eMBR to sMBRe by simply re-
versing the membrane module then the connections to the suction
pump and to air injection. The pilot has a maximum capacity of 60 L,
the work volume has been set to 32 L. A 3.1 kW cold unit regulates the
temperature of activated sludge at 25 ± 2 °C via 2 exchangers placed
at the recirculation loops of both biological tanks. HWW are contained
in a storage tank of maximum 200 L and are renewed every two days.
At first, HWW are sent in the denitrification tank (10.5 L) by the feed
pump enslaved to level rods. The tank is stirred by a recirculation of
sludge by a peristaltic pump. The bacterial flocs are kept in suspension
while avoiding the aeration of the anoxic zone allowing the deni-
trification reaction. A part of the recirculate sludge is transferred to the
aerobic tank with a 21.5 L sensitive volume, where the nitrification
reaction occurs. Hydraulic residence time (HRT) in both tanks is en-
sured by setting valves V6 and V7 to perform 1 h/2 h cycles in the
anoxic and aerobic tanks respectively. The flow of the transferred
sludge was controlled by reading the magnetic flow meter FI1 (Proline
Promag 10H, Endress Hauser). A fine bubbles aeration is produced by
four porous powered by a compressor. It maintains the oxygen con-
centration above 2 mg L−1 and helps stirring the aerobic tank. The air
flow is controlled by a ball flow meter (0–800 NL h−1, DK37, Khrone).
A centrifugal pump low pressurizes activated sludge at the bottom of
the nitrification tank towards the membrane module (B3, Motovario).
The circulation conditions of the sludge within the membrane module
depend on the MBR configuration. For the eMBR configuration the
circuit is under 2 bar pressure approximately. A tangential velocity
about 4 m s−1 is imposed in the membrane (Membrane Carbosep M1,
150 kDa, ZrO2-TiO2). This velocity is set by the V15 valve and by
reading the sludge recirculation flow on the magnetic flow meter FI2
(Proline Promag 10H, Endress Hauser). A back pressure micrometric
valve (V18) at the permeate outlet adjusts the permeate flow very
precisely. For the sMBRe configuration the sludge recirculation velocity
is very low compared to the external configuration. Frequency of the
peristaltic pump increases with acclimation to compensate the gradual
decrease of permeability due to the fouling of hollow fibers (Polymem,
M2; Polysulfone 100 kDa). Compressed air is injected under the form of
Fig. 1. Evolution of COD and ammonia in OWW during the 1st experimental campaign (eMBR).
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bubbles in order to limit the fouling by shearing. A flow meter controls
the air flow at 9 L min−1 (7.5 m3 m−2 h−1 for eMBR and
0.4 m3 m−2 h−1 for sMBRe). In addition, a relaxation and a backwash
are performed twice a day. In both MBR configurations, the retentate is
repressed in the nitrification tank while the permeate is sent in the
wastewater pipe from the oncology department. The operating char-
acteristics of both configurations are summarized in Table 2. A che-
mical cleaning of the membranes (recommended by the supplier) di-
rectly on the pilot is carried out when the gradual decrease of
permeability due to the fouling avoids achieving a sufficient permeate
flow.
2.4. Origin of activated sludge and analyses
The activated sludge used to inoculate the MBR comes from the
municipal wastewater treatment plant (municipal MBR) in Rousset
(Bouches du Rhône, France). They have been collected in a basin
containing biomass successively placed in aerobic and anoxia condi-
tions by cycles of aeration – no aeration of 10 min − 40 min.
(8.2 gMES L−1gMES L−1 for the first experimental campaign and
6.8 gMES L−1gMES .L−1 for the second). A daily follow-up of totally
suspended matters (TSS) and volatile suspended solids (VSS) con-
centrations is carried out to know the biomass evolution in the MBR.
NH4+ and NO3− are analyzed once or twice a week in HWW and in the
permeate. COD is also analyzed once or twice a week in HWW, in the
Table 1
Ratio of maximal concentrations detected in OWW, HWW and MWW (sMBRe).
Molecule OWW[ ]max presentstudy HWW[ ]max litterature OWWmax presentstudy
HWWmax litterature
[ ]
[ ]
MWW[ ]max litterature OWWmax presentstudy
MWWmax litterature
[ ]
[ ]
CP 687 5.73 Gomez-Canela et al. [22] 120 0.143 Steger-Hartmann et al. [57] 4804
IF 6820 10.647 Yin et al. [66] 640 0.029 Kümmerer et al. [36] 235172
SM 710 4.588 Kovalova et al. [34] 155 7.91 Peng et al. [46] 90
CD 47 50 Foster [19] 0.9 32.295 Kasprzyk-Hordern et al. [31] 1.5
Concentrations are expressed in μg L−1.
Fig. 2. PID of the MBR pilot.
Table 2
Operating conditions for both MBR configurations.
eMBR sMBRe
min max average min max average
Permeate flow rate
(L h−1)
1 2 1.42 ± 0.22 0.8 2 1.13 ± 0.27
Hydraulic retention
time (h)
16 32 23.0 ± 3.6 16 40 29 ± 8
Transmembrane
pressure (bar)
0.8 2.2 1.30 ± 0.23 0.06 0.75 0.39 ± 0.18
Sludge age Infini Infini
Aerated/not aerated
phases (h)
2/1 2/1
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activated sludge supernatant and in the permeate. Permeate and sludge
samples were collected the day after collecting HWW to comply with
the relatively long HRT to calculate the corresponding purification
yields. The sludge samples are centrifuged during 15 min at 13,500 rpm
(centrifuge 2–16, Sigma) then the liquid phase is filtered on a coffee
filter (average pore size 100 μm) to remove all the particles. HWW COD
is analyzed on the raw sample after passing through the pre-treatment
grid. The solid phase resulting from centrifugation is retrieved in an
aluminum plate placed in an oven (Nabertherm) at 105 °C during 24 h.
TSS concentration is obtained from the dry matter weighing. The oven
temperature is then set at 550 °C during 2 h to remove the organic
matter and obtain the VSS concentration by weighing difference be-
tween drying at 105 °C and oven at 550 °C. The COD is analyzed with
Aqua Lytic kits (20–150 mg L−1, Aqual Lytic). The BOD5 is measured
after 5 days (OxiTop, WTW). The NH4+ and NO3− concentrations are
determined with the Merck kits (2–150 mgN-NHH4 L−1mgN-NHH4 L−1
and 0–20 mgN-NO3 L−1).
Antibiograms are performed during the second experimental cam-
paign in order to assess the evolution of the biomass antibiotic-resistant
properties during acclimation. The 6 most consumed antibiotics in the
oncology department are selected for this follow-up. There are amox-
icillin and ticarcillin penicillins, cephalosporin antibiotics of third
generation ceftazidim and ceftriaxone, fluoroquinolone antibiotics ci-
profloxacin and carbapenem meropenem. Antibiograms are performed
according to the recommendations of the antibiogram committee of the
French society of Microbiology [6]. The activated sludge is diluted with
physiological water (9 g of sodium chloride by liter of distilled water)
until there is a turbid suspension equal to Mc Farland 0.5 standard
(∼108 UFC mL−1). Mc Farland 0.5 standard corresponds to a 0.132
absorbance at a 600 nm wave length. The performed solution can then
be diluted by a factor 10 or 100 according to the studied bacteria. The
absence of studies about the completion of an antibiogram on activated
sludge has imposed several preliminary tests. The 1/10th dilution of the
turbid suspension equal to the Mc Farland 0.5 standard has been se-
lected because it provides the “good number of bacteria/visible in-
hibition” compromise. Mueller-Hinton is the medium used because it is
suitable for the development of Enterobacteria, staphylococci and
pseudomonas and other non-fermenting negative Gram bacilli. The
medium is seeded by flooding using a Pasteur pipette. The surplus is
vacuumed and there is a 15 min air drying. With a sterilized clamp a
maximum of 3 antibiotic discs are then arranged equidistant on the
seeded agar. Boxes are incubated 24 h at 37 °C in aerobic conditions.
After incubation, inhibition diameters around antibiotics discs are
measured and the minimum inhibitory concentrations (MIC) are cal-
culated from those above and then compared with the activated sludge
of the municipal WWTP from Rousset (t = 0) to quantify the acquired
antibiotic resistance. 3 antibiograms are performed for each trial to
ensure the result repeatability.
3. Results with an eMBR
3.1. Biomass acclimation
The loading of the eMBR pilot was carried out with sludge from the
municipal WWTP at 8.2 g L−1 concentration in TSS. Throughout the
acclimation (Fig. 3a), the proportion of volatile suspended solids (VSS)
in the TSS is submitted to negligible variations (85 ± 3%).
After an initial loss (Phase 1) of half of the biomass observed from the
very first day after inoculation and undoubtedly due to the new conditions
which the biomass undergoes between the WWTP and the MBR, a sig-
nificant phase of bacterial growth is observed (phase 2) because the TSS
concentration increases from 3.4 g L−1 to 5.1 g L−1 between the 14th and
the 27th day. This significant phase of biomass growth between the 14th
and the 27th day could be explained by the consumption of soluble mi-
crobial products released during the cell lysis of phase 1 despite the low
incoming COD. Then there is a rough drop (phase 3) due to a modification
of the routine activity of the Oncology ward, shower and domestic waters
are mainly retrieved. Surfactants (soap and cleaning products) may have
disrupted mass transfers within bacterial flocs. From the 40th day, HWW
are retrieved during the whole night in order to get rid of shower waters.
An overflow was installed on the HWW storage tank for the continuous
sampling. A 2.0 g L−1 biomass growth at the 40th day and 3.7 g L−1 at the
96th day can be noticed on phase 4. F/M peaks between the 60th and the
80th days (Fig. 3b) are due to COD peaks in the HWW obtained despite the
night sampling, which allegedly harmonize HWW concentrations. This very
light bacterial growth on the long term shows the difficulties of the biomass
to acclimate to HWW. It is likely that the HWW, which contain a multitude
of drugs with high concentration, have an inhibitory effect on the growth of
activated sludge. From the 97th day, the drug load, which feeds the pilot
MBR, is diluted by half with a synthetic effluent in order to buffer the
incoming fluctuations and to allow the biomass to grow. Phase 5 corre-
sponds to the operation of the MBR feeded by half with HWW and with the
synthetic effluent. The first effect of the synthetic substrate intake has been
the stabilization around 0.20 kgCOD kgVSS−1.d−1 kgCOD kgVSS−1 d−1
(0.20 ± 0.05 kgCOD .kgVSS−1 .d−1). Despite the dilution by 2 of HWW, a
lot of fluctuations have been observed again in the biomass development.
Although the TSS evolution still tends towards a low growth from 3 6 g.L−1
at the 97th day to 4.6 g L−1 at the 160th day, it is less pronounced than the
one of phase 4 when HWW was the only substrate. The growth phase with
synthetic substrate is therefore 2.7 times lower than the growth of the
phase with HWW as only substrate. The slower growth can be the attrib-
uted to the average F/M 1,7 times stronger than during phase 4
(0.34 kgCOD kgVSS−1 d−1)kgCOD .kgVSS−1 .d−1) compared with phase 5
(0.20 kgCOD kgVSS−1 d−1). The slight biomass growth obtained on the long
term means that the acclimation to HWW is possible but remains very
tricky because of the effluent feature.
3.2. Purification efficiency
The overall reduction of COD via the MBR is always more than 90%
during acclimation except at the 123rd day where a one-time drop to
86% is noticed (Fig. 3b).
The removal of COD in the permeate (CODP) seems rather in-
dependent from the reduction of COD into the supernatant (CODS). The
membrane (150 kDa) is efficient on the COD retention not metabolized
by bacteria. At the 23rd day, a CODS stronger than the HWW would
confirm the attribution of the bacterial growth phase between the 14th
and the 27th day to the cell lysis, which occurred during the first ac-
climation phase. The significant biomass growth observed between the
14th and the 27th day can be explained by the consumption of released
extracellular polymers by the surviving bacteria.
Whereas the CODS removal has then increased, a gradual decrease
from 81 to 43% of the COD reduction from the 43rd to the 58th day
seems related to the decreases of the C/N ratio of HWW during
that period (between 15 and 21) and of the F/M after a peak
at 0.45 kgCOD .kgVSS−1d−1kgCOD .kgVSS−1.d−1 to the 43rd day. As
well, another decrease has been observed at the 83rd day, linked
again to drop of the C/N ratio (from the 48 at the 78th day to 16 at
the 82nd) and an important drop of F/M (from
0.72 kgCOD kgVSS−1 d−1kgCOD .kgVSS−1 .d−1 at the 78th day to
0.20 kgCOD .kgVSS−1 .d−1kgCOD .kgVSS−1.d−1 at the 82d day). The syn-
thetic substrate intake at the 97th day allows the stabilization of the
mass loading and of the C/N ratio between 14 and 25. These conditions
seem to favor the elimination of organic pollution since the reduction of
COD in the supernatant becomes more constant and always greater than
78% up to the end of the experimental campaign. Considering over this
period an elimination of 95% of the COD easily biodegradable from the
synthetic substrate, the elimination of COD from the HWW is very good,
since it lies between 73 and 91%, except occasionally at the 123rd day.
This decrease would indicate that a cell lysis caused by HWW and
would be confirmed by an occasional decrease of TSS at the 124th day.
Only a decrease of F/M from 0.33 at the 117th day to 0.14 at the 122nd
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day has been noticed since the C/N ratio is steady. The F/M decrease is
due to a lower COD concentration of HWW at the 122nd day, which
would have caused an occasional loss of biomass.
The ammonium reduction seems very low at the beginning of
acclimation (Fig. 3c) and then increases and stabilizes. It is however
noteworthy that very occasional drops (83rd day) may come from
HWW deficiencies. From the 97th day, the synthetic substrate intake
stabilizes the ammonium reduction over 92% with an upward
Fig. 3. Evolution of (a) TSS and the F/M ratio (eMBR) (b) the C/
N ratio and COD removal efficiencies in supernatant and
permeate (eMBR) (c) nitrates and ammonia removal efficiciency
in permeate and the ammonia F/M ratio during the 1st experi-
mental campaign (eMBR).
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tendency. At the 123rd day, it is noteworthy that a 100% reduction of
ammonium has been obtained whereas an occasional cell lysis is oc-
curring. This cell lysis would mainly affect heterotrophic bacteria.
The reduction of ammonium seems to be mainly influenced by the
fluctuations of the C/N ratio. A correlation between the peaks of
polysaccharides and the drop in the removal yield of ammonium has
already been observed [9,10,11]. The elimination of nitrates by the
MBR is largely incomplete during the 160 days of operation.
There are several possible causes for a malfunction of the deni-
trification reaction: unmet anoxic conditions [44], not enough organic
carbon [40], a wrong residence time between anoxic and aerobic zones,
an inadequate temperature and/or pH, an accumulation of nitrites or
the presence of toxic compounds Seifert et Domka [53]. So, the poor
denitrification performances could be the result of toxic compounds in
HWW disrupting heterotrophic bacteria. Little evidence was provided
in the literature about the influence of pharmaceuticals on the deni-
trification reaction. Kraigher et al. [35] show that the presence of drugs
on very specific conditions can lead to a modification of the bacterial
community and to a decrease of the performances of the denitrification
reaction. A light denitrification inhibition was also observed by Prado
et al. [48] in a MBR after the addition of the tetracycline antibiotic.
Surfactants in HWW are known as possible inhibitors of the deni-
trification reaction in the grounds [53]. HWW, which are rich in drugs
and surfactants because of the strict hygiene standards of healthcare
services, seem to be responsible for the denitrification inhibition. The
dilution of HWW by the synthetic substrate free of drugs and surfactants
that allowed a partial denitrification highlights this observation.
The evolution of membrane fouling is analyzed by the monitoring
pressures at the end of the membrane module, which allows the cal-
culation of the transmembrane pressure (TMP) then the permeability.
The evolution of the normalized permeability (at the initial value
Lp20 °Cmax listed = 58.6 L h−1 m−2 bar−1) is divided into several dis-
tinct phases corresponding to the washing and to the feeding change of
the MBR. The initial water permeability of the membrane Lp0, mea-
sured at 102 L h−1 m2 bar−1, is consistent with the value given by the
manufacturer. The membrane permeability decreases linearly until the
40th day during the phase 1. Phase 2 from the 40th day to the 96th day,
which corresponds to the change of sampling method and of feeding of
the MBR by HWW alone, is characterized by a new linear drop in the
loss of permeability similar to the one of phase 1. The membrane had to
be cleaned on the 97th day because of a more important TMP to reach a
sufficient permeate flow. Phase 3 from the 97th day to the 160th day,
which corresponds to the MBR fed by HWW and the synthetic substrate,
is characterized by a loss of linear permeability versus time less im-
portant than in phase 2. The daily loss of membrane permeability was
then reduced by 28% during the HWW dilution by a synthetic substrate.
The reduction first indicates that the mixed liquor has become less fo-
uled with the synthetic substrate intake than in phase 3.
3.3. Performances of eMBR on the removal of 5-FU
Except on the 150th day, 5-FU has been systematically detected in
HWW for the analyzed samples (Fig. 4). Concentrations vary from 0 to
1,287 μg L−1. These concentrations are very important compared with
those observed in previous studies between 35 ng L−1 and 122 μg.L−1
[41]. The analyzed permeate samples indicate a good removal of 5-FU
by the eMBR since the reductions are more than 90% (Fig. 4) whatever
the initial concentration. Note that the concentration of 5-FU in the
supernatant was always similar to the concentration in the permeate,
ruling out the assumption of a retention of this pharmaceutical by the
membrane in the biological tank or on the membrane.
Despite the very strong concentration more than 1 mg L−1 in HWW,
the elimination of 5-FU remains above 95%. The specific elimination
rate constant seems relatively proportional to the initial concentration
in 5-FU (pseudo first order). Therefore, 5-FU is almost entirely removed
via biotransformation [41]. Degradation kinetics of 5-FU were achieved
on sludge from the municipal WWTP from Rousset (France) and on
sludge from hospital eMBR for 5 initial concentrations:
50–100–200–500–1000 μg.L−1. Kinetics were carried out on 21 h in
order to match the HRT of the eMBR. Sludge from the municipal WWTP
is adjusted to the sludge concentration from the eMBR: 4.1 g L−1.
Whatever the concentration, the reduction of 5-FU is always higher for
acclimated sludge from the hospital than sludge collected in the mu-
nicipal WWTP. In this concentration interval, activated sludge from the
municipal WWTP also seems very efficient on the elimination of 5-FU
since the minimum reduction is always above 80%. It is however very
important to note that despite the various drugs, metabolites and
cleaning products in HWW, the biomass from hospital eMBR proved to
be at least as successful as the sludge from the WWTP, which degraded
5-FU alone. Kinetic constants of kbiol degradation were calculated be-
tween t = 15 min and t = 90 min since on this interval the term ln(C/
C0) is linear and indicates that the degradation kinetics is of pseudo-first
order during the 90 first minutes (Fig. 5). The evolution of the constant
of kbiol degradation shows that acclimation step allows a faster de-
gradation of 5-FU. An average increase by 34% is then reached for the
eMBR sludge treating HWW compared with sludge in the WWTP. The
evolution of kbiol constants shows that a threshold was reached for
sludge in the WWTP whereas it may still evolve after 1000 μg L−1 for
sludge in the eMBR treating HWW. So, the minimum inhibition con-
centration may be lower for sludge in the WWTP than for sludge in the
hospital eMBR. The removal of 5-FU is attributed to either bio-
transformation or sorption [25].
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Fig. 4. 5-FU concentrations detected and removal efficiency in oncological
ward wastewater and 5-FU removal efficiency during the 1st experimental
campaign (eMBR).
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4. Results with a sMBRe
This second experimental campaign to acclimate activated sludge to
HWW was conducted with the configuration of external submerged
membrane bioreactor (sMBRe). In this configuration, the used mem-
branes are hollow fibers with a 100 kDa cutoff. It is noteworthy that the
membrane surface has doubled from 0.2 to 0.4 m2 from the 56th day.
New indicators of the biomass acclimation to HWW were tested during
the second campaign such as antibiotic resistance and respirometry
tests. Purification efficiency on the drug pollution is assessed on 4 drugs
among which 2 out of the 3 most consumed anticancer drugs in the
oncology ward (ifosfamide and cyclophosphamide), one antibiotic
(sulfamethoxazole) and one painkiller (codeine).
4.1. Acclimation
HWW were continuously collected during the night. The evolution
of carbon (COD) (from 148 to 1135 mg L−1) and nitrogen (N-NH4+)
(from 7 to 69 mg L−1) pollution show a lot of fluctuations of COD and
ammonium concentrations during the 180 acclimation days (Fig. 6).
This concentration discrepancy logically implies an uneven trend of the
C/N (COD/N-NH4+) ratio of HWW. The main sampled HWW have a C/
N ratio comprised between 5 and 30. The average C/N ratio of 17.9 is
thus lower than during the first campaign (32.3) indicating a nitrogen
amount more important versus carbon but closer to the ideal desired
ratio of 20.
4.2. Overall performances of the sMBRe
The loading of the sMBRe hospital was carried out with activated
sludge from the municipal WWTP from Rousset (France). The initial
TSS concentration is 6.8 g L−1. The TSS and F/M evolutions were di-
vided into 4 distinctive phases (Fig. 7a). Purification efficiency on COD,
ammonium and nitrates were also presented as the 4 phases were de-
scribed (Fig. 7b–c). The second experimental campaign was marked
again by an almost continuous intense foaming of the mixed liquor in
the aerated tank reflecting the bacterial stress exerted by pharmaceu-
ticals and/or the significant presence of surfactants contained in HWW.
During the first experimental campaign, one of the assumptions to
explain the low biomass growth over the long term was about some of
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Fig. 5. Evolution of the degradation constant kbiol for both activated
sludges from eMBR hospital and municipal WWTP.
Fig. 6. Evolution of COD and ammonia in OWW during the 2nd experimental campaign (sMBRe).
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the specific compounds of HWW that would exert an inhibition on the
reproductive abilities of microorganisms. It was thus decided to apply
conditions of limiting substrate to the biomass to get microorganisms
used to the presence of specific substances contained in HWW and to
force their degradation. This strategy of limiting substrate explains the
low average F/M value in COD to 0.09 kgCOD kgVSS−1 d−1 during the
first 50 days. The average COD concentration in HWW lower by 28% on
COD during the 2d campaign compared with the first one led to apply
Fig. 7. Evolution of (a) TSS and the F/M COD ratio (sMBRe) (b) of COD
removal efficiencies in supernatant and permeate and C/N ratio
(sMBRe) (c) of nitrates concentration in permeate, the ammonia F/M
ratio and the removal efficiency of ammonia during the 2nd experi-
mental campaign (sMBRe=.
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occasional F/M sometimes very low. Further to the problems faced on
the biomass performances, acclimation was then conducted with a
double membrane area (0.2–0.4 m2) from the 56th day to apply a
higher F/M. According to the first experimental campaign, the VSS rate
in TSS remained relatively constant during acclimation to 88 ± 3%.
4.2.1. Phase 1: 0–30th day
Unlike the 1st experimental campaign, the biomass concentration
remained relatively steady during the first days. The hydrodynamic
conditions of the sMBRe configuration are indeed softer than the ex-
ternal configuration (eMBR) since it is not necessary to impose a high
flow velocity within the membrane, as fouling is controlled by the in-
jection of air bubbles in the membrane module. Contradictory evolu-
tions are noted for biomass and the removal of CODS during this first
phase: (i) The minor loss of TSS observed until the 16th day to 5.4 g L−1
indeed coincides with a proper removal of CODS while (ii) the phase of
growth, which returns to the initial concentration of 6.8 g L−1 in the
22nd day, is bound with the rough decrease of the reduction of CODS
between the 16th and the 22nd day. The drop seems to be the result of a
very low F/M to 0.04 kgCOD kgVSS−1 d−1 because of HWW rather less
loaded that on the 16th day. The removal of ammonium also fluctuates
slightly. Autotrophic bacteria could be occasionally sensitive to a pre-
sent compound or a lack of inorganic carbon in HWW since the removal
of ammonium has reached again the correct values from the 22nd day.
Meanwhile, a pronounced inhibition of denitrification occurs early in
this second experimental campaign despite a limited potential con-
stitution of nitrates due to the weak removal of ammonium.
4.2.2. Phase 2: 30–69th day
After TSS stabilized until the 30th day, the phase is at first marked
by a very slow loss of biomass until the 53rd day to 5.9 g L−1 then by a
decrease to 3.9 g L−1 on the 68th day because of a technical problem.
On the 69th day an overall drop in the sMBRe performances has been
noticed with CODS and ammonium removals to 9% and 44% respec-
tively. This drop can be the result of the technical problem but also of
the very important variation of the C/N ratio, from 65 to 4.5 from the
61th to the 68th day [21] but autotrophic bacteria seem to have better
withstood these conditions than heterotrophic bacteria, namely that the
C/N ratio only is not enough to explain this overall drop in the sMBRe
performances. Denitrification seems very effective as evidenced by re-
moval of 97% of ammonium on the 50th day indicating a high potential
for the constitution of nitrates. The little CODS removal during this
period also highlights a significant retention by the membrane of the
non-degraded COD to obtain an apparent high removal despite altered
biological performances. A partial reloading was performed on the 69th
day with activated sludge of the STEP from Rousset to compensate for
the generated losses, for the TSS concentration of the sMBRe going back
then up to 5.6 g L−1. The sMBRe hospital is thus made up with 30% of
non-acclimated activated sludge from the municipal WWTP on the 69th
day.
4.2.3. Phase 3: 70–115th day
A new continuous biomass loss has been observed during phase 3.
This more pronounced loss resulting from reloading since the TSS
concentration fell from 5.6 to 4.4 g L−1 from the 70th to the 78th day
then decreased albeit moderately, similarly to phase 2 until the 100th
day to reach 4.1 g L−1. It is associated with an uneven CODS and a very
good ammonium removal probably related to the relative stabilization
of the C/N ratio. However, the implementation of a double membrane
surface involves a decrease of the CODP reduction. The higher mem-
brane area available slows down the fouling impact on the retention of
the non-biodegraded residual COD. A second partial reloading in two
steps, on the 109th and 115th days was necessary to compensate for
biomass losses, TSS concentrations then came back up to 4.1 g L−1 and
was then made up with 44% non-acclimated activated sludge on the
115th day.
4.2.4. Phase 4: 115–180th day
A slow biomass loss similar to the one in phases 2 and 3 has started
again. Partial reloading has likely affected the CODS removal im-
mediately with a rough drop to 10% on the 116th day, but not am-
monium removal with 98%. On the contrary, ammonium removal fell
to 52% on the 121st day whereas CODS removal came up to reach
values above 70%. The results indicate again that autotrophic and
heterotrophic bacteria are affected in a different way by HWW. From
the 144th to the 157th day, a significant biomass increase from 2.9 to
4.3 g L−1 was obtained and linked to a relatively steady and ideal C/N
ratio (it is included between 15 and 20) and with a strong F/M. The
permeate flow was increased noticeably since the 136th day in an at-
tempt to get bacterial growth again (from 1 L h−1 since the beginning
of phase 4 to an average of 1.35 L h−1 between the 136th and 157th
days). This phase of growth has also been marked by the absence of
foam in the reactor for the first time since the start of biomass accli-
mation, indicating a significant decrease in the medium toxicity and/or
the absence of surfactants in HWW. Good purification efficiency was
related to the bacterial growth.
HWW have a very strong inhibitory effect on the reproductive ca-
pacities of biomass that does not seem to respond well to changes in
composition of the effluent. Conflicting performances were observed in
similar operating conditions throughout the acclimation and would
mean that the specific composition of HWW is responsible for the an-
tinomy by the observed performances of biomass of the sMBRe hospital.
It is thus possible that HWW do not affect both types of bacteria with
the same kinetics by HWW nor over the same duration. The CODS re-
moval has experienced a lot of fluctuations, which seem to be linked to
the variations of C/N ratio. The 4 carbon peaks on the 61st, 98th, 105th
and 158th days have all caused a dramatic drop in the CODS reduction.
On the contrary, the carbon peaks did not systematically alter the
performances of autotrophic bacteria. So, a selective inhibition of het-
erotrophic bacteria was noticed occasionally with an operational de-
nitrification and a very weak COD removal. The non-repeatability of the
results indicates that the follow-up of conventional indicators of HWW
pollution does not allow the full use of the MBR pilot since the in-
hibition of activated sludge sometimes seems related to specific pollu-
tants and not to the proportion of carbon and nitrogen in HWW. The
fouling of 100 kDa hollow fibers has a major influence on the retention
of CODS and achieves excellent overall COD removal by sMBRe despite
significant fluctuations in purification performance of biomass.
Similarly to the first experimental campaign, the denitrification reac-
tion proved again very inhibited throughout acclimation while the
physical and chemical parameters (temperature, dissolved oxygen, pH)
were optimum to provide an operational denitrification. Two experi-
ments in batch reactor were performed at the end of the 2nd experi-
mental campaign to check whether inhibition of the denitrification
reaction could come from the lack of easily assimilated carbon: (i) an
anoxic batch reactor in endogenous condition (no outer substrate in-
take); (ii) an anoxic batch reactor in exogenous condition (with organic
carbon intake easily biodegradable (sugar)).
The dissolved oxygen concentration was controlled and remained
null during the experiment. No denitrification was observed in both
batch reactors after 4 h experiment, nitrate concentrations remained
constant. So, inhibition of the denitrification reaction does not come
from the absence of organic carbon easily digestible. The observations
of the first experimental campaign would therefore be confirmed: de-
nitrification inhibition would be caused by products disturbing the
transfers of material within the bacterial flocs in the anoxia tank. These
products, such as surfactants, in large quantities in HWW because of the
hospital activity could also be partly responsible for the foaming of the
mixed liquor observed in almost all of the second experimental cam-
paign. These products would disrupt less heterotrophic bacteria in the
aerobic tank because of their partial degradation due to presence of
dissolved oxygen in this tank.
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4.3. Membrane fouling
It should be noted that the membrane surface was doubled from
0.2 m2 à 0.4 m2 from the 56th day in order to apply higher F/M. The
representation of the membrane fouling evolution was achieved from
the fouling resistance (Rfouling) obtained from a resistance model
(Fig. 8). TMP and flux varied during the 180 days of the campaign
depending on membrane fouling, membrane ageing, TSS concentra-
tions, etc. The TMP varied from 0.06 to 0.75 bar and the flux from 2 to
5 L h−1m−2. The membrane fouling was calculated from these values.
From the 12th day of acclimation a relaxation (one minute) and a
backwash (1 min–0.5 bar) of the hollow fibers were performed manu-
ally twice a day in order to slow down the fouling constitution. Several
incidents (fiber break, technical problem) occurred during the 180 days
of the sMBRe operation. The fouling evolution is roughly similar for the
two first phases with the 0.2 m2 surface membrane module. With the
double surface membrane module, the loss of permeability is initially
more important because of a higher permeate flow and because of the
significant TSS loss at that period that could lead to a release of soluble
microbial products conducive to fouling. The fouling formation kinetics
can then be compared with the one of the 55 first days and corresponds
to a relative stabilization of TSS and to a similar permeate flow. The
forthcoming phase, from the 96th to the 125th day is characterized by a
faster fouling formation and coincides with important fluctuations of
the TSS concentration and with reloading of activated sludge. The cell
lysis could therefore lead again to the release of compounds with a
strong fouling capacity. Kinetics of the fouling formation is then atte-
nuated in the biomass stagnation and growth and indicates the good
physiological state of activated sludge. The role of the biomass state is
thus significant in the membrane fouling formation since the phase is
associated with an important increase in the permeate flow. The fouling
degree has a major influence on the CODS retention not removed by
bacteria (Fig. 8). The retention rate (RR) of CODS becomes rapidly
important and remains high until the 93rd day and the change of
membrane module because of a broken hollow fiber. This high reten-
tion is associated with a rapid drop of the membrane permeability,
despite a fiber backwash and relaxation, and of the chemical cleaning of
the 21st day too. For a similar permeate flow, when the membrane
surface is doubled, the CODS retention rate is weaker and fluctuates.
From the 93rd day, the operation with higher membrane permeabilities
directly influences the CODS retention rate, which oscillates between 30
and 63% until the 139th day. The implementation of a new membrane
on the 145th day confirms the major influence of fouling on the CODS
retention since it becomes null. Although operating with a significant
fouling degree improves the apparent CODS removal, the important
retention of specific substances in the reactor could be an assumption to
explain the occasional alterations of the biomass purification efficiency
(Fig. 9).
It is noteworthy that long-term TSS drops are obtained from the
23rd to the 105th day whereas the average COD retention rate of the
surfactant is 67%. Then, the average CODS retention factor is only 38%
and coincides with the biomass stabilization and growth phases. The
last low values of the CODS retention factor correspond to the last
change of membrane module. An important CODS retention by the
membrane and its fouling could lead to the accumulation of the toxic
compounds in the biological reactor, which would disrupt the biomass
growth. These observations thus provide another assumption regarding
the parameters that could influence the biomass growth.
4.4. Antibiotic resistance and purification efficiency
Antibiograms were performed to quantify the evolution of antibiotic
resistant properties of the biomass during the second experimental
campaign. The acquisition of the antibiotic resistance is reported to
occur at sub-inhibitory concentrations, which favor the development of
antibiotic-resistant bacteria [24]. The 6 most consumed antibiotics in
the oncology unit to which the sMBRe hospital is connected have been
selected for this follow-up. There are penicillin types amoxicillin and
ticarcillin, cephalosporin antibiotics of third generation ceftazidime and
ceftriaxone, fluoroquinolone antibiotics ciprofloxacin and carbapenem
meropenem. The minimum inhibitory concentration (MIC) of anti-
biotics on activated sludge is calculated from measured inhibitory
diameters. The biomass MIC of the sMBRe are compared with those of
the municipal WWTP from Rousset (MIC0) to quantify the acquired
Fig. 8. Evolution of the membrane permeability, the supernatant COD retention rate and TSS (×10) during the 2nd experimental campaign (sMBRe).
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antibiotic resistance (Fig. 10). So, the higher the ratio MIC/MIC0 is, the
more the biomass develops an antibiotic resistance. The overall anti-
biotic resistance of activated sludge has logically increased during ac-
climation. Biomass has rapidly become completely resistant to both
types of penicillin. This result is not surprising since initial activated
sludge of the municipal WWTP already showed an important resistance
to both antibiotics with a MIC0 far higher than for other molecules
(Table 3). The amoxicillin measured antibiotic resistance agrees with its
removal in the conventional WWTP with activated sludge since 100%
removals were observed [63,70] and 99% [64].
The maximum antibiotic resistance degree has been reached for
most antibiotics on the 99th day when ciprofloxacin and ceftriaxone
can no longer be quantified. At that time, the COD reduction in the
supernatant has come back up to 78% but ammonium dropped to 10%
after the carbon peak in HWW. The carbon peak on the 98th day
combined with an increase in F/M induces the simultaneous decrease of
the antibiotic resistance of meropenem, ticarcillin and ciprofloxacin
between the 99th day and the 105th day. So concurrently to the TSS
evolution and to the CODS removal, the biomass antibiotic resistant
properties could also be short-term impacted by the significant com-
position fluctuations of HWW. On the contrary, the biomass was com-
pletely ceftazidime resistant on the 105th day. The decrease of
Fig. 9. Influence of the COD supernatant retention rate on the evolution of the biomass concentration (sMBRe).
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ceftazidime resistance on the 114th day could be due to a latency re-
quired for this antibiotic or to partial reloading with activated sludge
less resistant than sludge developed in the hospital sMBRe, which
would specifically altered this antibiotic resistance. Antibiotic re-
sistances of ciprofloxacine, ceftriaxone and ceftazidime keep on evol-
ving until the end of acclimation whereas the meropenem resistance
seems to reach a stage. Meropenem is besides the only tested antibiotic,
which has always had an inhibitory effect that can be quantified on
microorganisms [1]. Biomass has however gained a significant re-
sistance to this antibiotic over time because it is 35 times stronger than
the municipal WWTP sludge. Another degradation test showed the non-
biodegradability of ceftriaxone [30], which can explain its very low
MIC0. Ciprofloxacin is partly removed in the municipal conventional
WWTP, its reduction lies between 18 and 89.8% [42]. So, ciprofloxacin
resistance is acquired more slowly than for penicillins but is higher
(resistance cannot be measured at the end of acclimation) than for
ceftriaxone.
The resistance acquisition via biomass seems to agree with the an-
tibiotic classification. Biomass has indeed become easily resistant to
both penicillin types and the MIC0 and MIC163j for both cephalosporin
types are of the same order of magnitude. Antibiotic resistance seems to
be true for antibiotics with the same mode of action [39]. A specific
antibiotic does not need to be in HWW for the bacterial community of
activated sludge to become resistant since it can develop a crossed re-
sistance via another antibiotic in feed. The strong acquired resistance to
both penicillin types is not surprising because apart from their high
MIC0, both antibiotics are by far the most frequently consumed in on-
cology ward. A crossed resistance to cephalosporin of 3rd generation
can also be carried out via cefixime, however consumed in small
quantities in the ward. Finally, carbapenems are known to be anti-
biotics stronger than penicillins and are therefore used as a last resort
when other antibiotics did not work. Meropenem is the only carba-
penem used in the oncology ward, its usage specific to critical cases
combined with a systematic efficiency justifies the lowest resistance
degree reached compared with another tested antibiotic. However, the
resistance at the end of acclimation is identical to the amoxicillin initial
one. The meropenem resistance stagnation may be due to its absence in
HWW during a prolonged period.
After 180 operating days, biomass has developed a very strong re-
sistance to the tested antibiotics, from 35 times more to completely
resistant. The results demonstrate the adaptation abilities of micro-
organisms to molecules initially designed to destroy them. Despite the
difficulties to obtain a significant biomass growth during the second
experimental campaign, it is noteworthy that antibiotic resistance is
still evolving for some antibiotics. A stage seems to be reached re-
garding meropenem, which is the antibiotic with the most significant
inhibitory effect on biomass throughout acclimation to HWW. These
results confirm Stadler’s results [56] that highlighted the influence of
HWW on the bacterial diversity and the dissemination of resistant genes
within the bacterial community. So, very concentrated antibiotics in
HWW compared with UWW favor the development at a high degree of
antibiotic resistance within the purification biomass.
Table 3
Membrane retention rate for the supernatant samples analysed (sMBRe).
Date Molecule OWWtotal
(μg L−1)
Supernatant
(μg L−1)
Biological reactor
removal
efficiency (%)
Permeate
(μg L−1)
MBR total
removal
efficiency (%)
Retention rate
pharmaceutical (%)
Rfouling
(m−1)
COD
retention rate
(%)
CODS
(mg L−1)
115th day CD 375 80 78.7 15 96.0 81.3 3.9.1013 50.9 133.6
CP 687 552 19.7 76 88.9 86.2
IF 1030 809 21.5 73 92.9 91.0
SM 1190 57 95.2 3 99.7 94.7
128th day CD <LQ <LQ – <LQ – – 1.3.1013 27.2 95.6
CP 450 278 38.2 205 54.4 26.3
IF 900 614 31.8 578 35.8 5.9
SM 2000 2170 −8.5 1460 27.0 32.7
143rd day CD 375 108 71.2 87 76.8 19.4 6.1.1012 0 123.6
CP 609 386 36.6 307 49.6 20.5
IF 1620 1010 37.7 800 50.6 20.8
SM 2500 1530 38.8 482 80.7 68.5
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Fig. 11. Concentrations of the selected pharmaceu-
ticals in OWW (before doping) (sMBRe).
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4.5. Detection of the selected drugs and removal via sMBRe
The MBR performances are quantified from anticancer ifosfamide
(IF) and cyclosphosphamide (CP), sulfamethoxazole (SM) antibiotic and
codeine (CD) painkiller. As well as 5-FU, IF, CP and SM are highly
concentrated in the sampled HWW (Fig. 11). Very important con-
centrations were collected for ifosfamide: 6.8 mg L−1 on the 98th day
and 2.6 mg L−1 on the 158th day. Detection frequencies and con-
centrations obtained show the strong variability of the pharmaceuticals
composition of the collected HWW. Indeed, as the MBR is only con-
nected to 6 rooms, the composition of the collected effluents depends
on a number of patients (maximum 9) with different pathologies. The
very strong drug identified concentrations can once again be allocated
(i) to the discontinuous sampling during the night to avoid dilution of
HWW by shower waters and (ii) originally HWW only from patient
rooms. IF, CP and SM concentrations in HWW are logically higher than
the ones in overall HWW of the previous studies (Table 1). To ensure
the presence of the selected drugs in the feeding source of the MBR pilot
and to quantify the sMBRe performances on their removal, HWW col-
lected in the storage tank were exceptionally doped on the sampling
days with random but known concentrations. The purpose was to
maintain the HWW fluctuating specificity and to study the influence of
the initial concentration on the sMBRe performances. Considering the
high-identified concentrations in 5-FU, the applied doping is important
(Table 4). It should be noted that these drug supplements are however
too weak to influence the biomass performances. IF and CP doping are
far below the concentrations contained in the sampled HWW. CD
doping was overestimated but its whole concentration in the feed re-
mains low versus other drugs. SM was overestimated too.
The permeate sample is collected after a minimum time equal to the
HRT of sMBRe in order to meet the sampling representability. The
evolution of the drug reductions selected by the sMBRe are presented
on Fig. 12. The reductions are calculated from the drug concentrations
in feed (sampled HWW + doping) and in the permeate. Just like the
purification of conventional pollution, the drug removal via hospital
sMBRe was submitted to various fluctuations during the experimental
campaign. The removal of the 4 drugs increased until day 115 except
day 98 with 22% removed IF. This low apparent removal of IF at that
time corresponds to its maximum concentration identified in HWW
(8.32 mg L−1 with doping). A 1.83 mg L−1 difference between feed and
permeate is however noticed and indicates that the sMBRe proved ef-
fective. With such a considerable concentration, ifosfamide is liable to
have an inhibition because its removal no longer depends only on the
initial concentration. During this period, SM is still removed over 96%,
CD and CP over 67%.
An excellent overall removal of the 4 drugs was obtained on day
115. CP was the less removed molecule with 89%. The analysis of the
reactor supernatant at that time showed that the retention rate by the
membrane of codeine, cyclophosphamide, ifosfamide and sulfa-
methoxazole in the sMBRe supernatant was 81, 86, 91 and 95% re-
spectively (Table 3). The analysis of both other supernatant samples on
the 128th and 143rd days confirmed a drug retention by the hollow
fiber membranes (rather limited).
The results are very surprising since all the studies agree on the fact
that microfiltration or ultrafiltration membranes used in MBRs cannot
retain drug molecules because they are very small, generally around
200–300 Da. They are at least 100–1000 times smaller than the mem-
brane cutoff [29,55]. In an eMBR pilot, Delgado and Seira [14,54] did
not observe any retention of cyclophosphamide by the ceramic mem-
brane with a 0.2 μm MWCO. This MWCO, which corresponds to
400 kDa approximately, is 4 times higher to the 100 kDa hollow fiber
one used during this experimental campaign. Recently, Zaviska et al.
[67] identified over 60% CP retention in a MBR-NF when the fouling of
the nanofiltration membrane with a 600 Da cutoff has become more
important.
The results show that fouling of hollow fiber membranes with a
100 kDa MWCO 330–400 times bigger than the size of the selected drug
molecules, can be an important drug retention mechanism in the
sMBRe, even major in a serious fouling. However, fouling cannot ex-
plain alone the results obtained since the drug retention on the 143rd
day with an almost new membrane proved more significant than the
one on the 128th day with a moderate fouled membrane. The mixed
liquor properties, the biomass physiological state and the fouling nature
could have an important role in the retention of the selected drugs.
The study of the COD and ammonium removal in the supernatant as
well as F/M ratio in COD and ammonium on times corresponding to the
available data on drug concentrations in the supernatant outline a
difference of behavior according to drug molecules (Table 5). Indeed,
the reduction in the reactor by 78% for CD and 95% for SM on the
115th day no longer presents an inhibition of heterotrophic bacteria. It
is indicated by a reduction of CODS less than 10% and low COD and
ammonium concentrations of HWW. The major quantity of metabolized
SM shows that the biotransformation via co-metabolism has not been
limited by low COD and ammonium contents. The result also shows the
key role of autotrophic bacteria on the SM and CD removal. Conversely,
the removal in the reactor of about 20% CP and IF appears substantially
altered by this inhibition of heterotrophs and/or the very low COD and
ammonium contents on the 115th day. Their biological removal lies in
fact between 31 and 38% for the 2 other dates coinciding with a better
CODS reduction and concentrations of COD and ammonium respec-
tively 2.5 and 6 times higher than on the 115th day. The quantity of
substrate available could therefore play a major role on the
Table 4
Total concentrations (OWW + doping) of selected pharmaceuticals in the feeding source of the sMBRe.
Molecule Day
70 84 98 115 128
CD 180 100 391 96 523 96 375 100 0 0
CP 1195 84 500 100 0 0 687 0 450 100
IF 1828 82 900 100 8320 18 1030 97 900 100
SM 58 0 1290 100 1180 100 1190 42 2000 100
Molecule Day
143 158 165 171
CD 375 100 0 0 19 0 47 0
CP 609 74 272 0 203 0 388 64
IF 1620 62 3486 26 517 0 965 26
SM 2500 100 1000 100 729 69 1710 58
Concentrations units are in μg L−1. The numbers in italics indicate the percentage due to doping in relation to its total concentration in the feeding source.
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biotransformation of both molecules. It should however be noted that
the excellent removal of ammonium on the 143rd day is not related to a
removal of SM as significant in the reactor. Again, it demonstrates the
great complexity of interaction of the parameters, which influence the
drug removal. The drug retention by the membrane and its fouling does
not allow the analysis of the influence of COD and ammonium
Fig. 12. Evolution of the selected pharmaceuticals removals by sMBRe.
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concentrations in HWW on the removal of the selected drugs for the
periods when data on the supernatant are not available.
An overall drop of performances to remove the selected drugs has
been noticed after the 115th day. This drop could be the result of a
weaker membrane fouling after the sampling dates. It could also be the
result of the biomass affected by the various reloading involving a
partial loss of the acclimation advantages on the degradation of drug
molecules. The latter assumption could be rejected for CP and IF in
terms of reduction in the reactor far higher on the 128th and 143rd days
than on the 115th day. So, the drop in the overall removal could be
partly the result of the sMBRe hospital operation at less important
fouling levels.
Sulfamethoxazole and codeine are the best removed molecules by
sMBRe with respectively 75 and 72% mean elimination (Table 6). The
removal of both anticancers proves less with 60% on average for cy-
clophosphamide and 49% for ifosfamide. The interest of the re-
presentation of the reduction by the sMBRe according to the con-
centration of the initial feeding is limited due to the retention by the
membrane and the fouling of the selected drugs distorting the actual
concentrations of drugs upstream of the membrane.
The CD elimination recorded during this study meets the order of
magnitude of the best performances in the literature [65,51,16]. Note
that these performances were performed for UWW with codeine con-
centrations lower than 3 log (in comparison with this study) and that
the 2 best removals are obtained via MBR. A lot of data are available in
the literature about the SM removal. Apart from some studies about
conventional processes with activated sludge for which low reductions
were identified [5,60,31], the SM removal is generally higher or around
70%. The study is close to the present work, because it is about the
treatment on the spot of overall HWW via MBR [34] and shows a SM
reduction very low by 7% marked by a large variability with an initial
concentration to 3.476 ± 4.588 μg L−1 far less than the one noticed in
the present study. The best performances obtained with an average SM
removal of 75.0% show that it is possible to remove the drug directly on
the site at a high level. It should be noticed that a part of this im-
provement towards the study [34] could come from the doping method
of HWW by adding SM only without the human metabolite being able
to recombine SM during the biological treatment.
The average 59.5% CP removal obtained during this study is similar
to Seira’s [54], which rely on a sampled UWW doping too but for far
more important input concentrations. The only study treating on site
hospital effluents via MBR has a CP removal less than 20% [34]. It is
noteworthy that their study focused on the overall hospital HWW re-
sulting in an average input CP concentration of 0.161 ± 0.026 μg L−1
consequently 3–6 log weaker than the present study. Zaviska et al. [67]
also observed a CP retention by their NF membrane up to 60% allowing
a maximum removal of 80% via their MBR-NF. So, in this study the
serious membrane fouling on the 115th day had the best CP removal
listed to 88.9% for a MBR treating an actual effluent on the site. There is
no observation in the literature of IF removal via conventional activated
sludge WWTP. The average 49.3% removal in this study is the first
positive result about the removal of the most used anticancer in the
oncology ward of the study. Average identified purification efficiency
on drugs agrees with the literature for CD, SM and CP. The perfor-
mances were achieved by treating HWWwhose inhibitory effects on the
bacterial growth and on the regularity of the purification efficiency
were demonstrated. Besides, the hospital sMBRe could degrade these
drugs at high concentrations, of several logs in some cases towards the
previous studies identified in the literature. The results justify both the
treatment strategy on the issuing site for treating a highly concentrated
drug effluent and the choice of the MBR process to both improve the
biological removal of the selected drugs and physically retain a sig-
nificant fraction of drug residual concentration by the membrane in
case of serious fouling.
5. Conclusion
The follow-up of purification efficiency of the eMBR on drugs has
been carried out on the three most consumed anticancer drugs: ifosfa-
mide (IF), fluorouracil (5-FU) and cyclophosphamide (CP); the codeine
painkiller (CD) and the sulfamethoxazole antibiotic (SM) were added to
this study. The sampled oncological ward wastewater (HWW) are out-
lined by a high variability of composition, some concentrations mea-
sured in 6.82 mgIF .L−1, 1.28 mg5-FU .L−1, 687 μgCP .L−1 and
710 μgSM .L−1 are the highest concentrations in the literature with an
order of magnitude greater than 2 log compared with overall hospital
effluents. These composition fluctuations have not made acclimation of
activated sludge from a municipal WWTP easy in the MBR pilot. A low
biomass growth was observed after 160 days with the eMBR whereas
there was an almost continuous loss for acclimation based on sMBRe.
However, during acclimation with sMBRe, a significant bacterial
growth obtained at the end of the campaign indicates that inhibition
from HWW on the biomass reproductive abilities is not irreversible and
Table 5
Performances of sMBRe for the removal of COD in supernatant and ammonia for the selected dates.
Date Molecule Reactor removal
efficiency (%)
Total removal efficiency
(%)
CODS removal efficiency
(%)
N-NH4+ Removal
efficiency (%)
DCOOWW
(mg L−1)
N-NH4+OWW
(mg L−1)
115th day CD 78.7 96 10 98 148 8.9
CP 19.7 88.9
IF 21.5 92.9
SM 95.2 99.7
128th day CD – – 76 79 409.6 61.7
CP 38.2 54.4
IF 31.8 35.8
SM −8.5 27
143rd day CD 71.2 76.8 69 96 399.6 50
CP 36.6 49.6
IF 37.7 50.6
SM 38.8 80.7
Table 6
Synthesis of the performances of the sMBRe on the removal of the selected pharmaceu-
ticals.
Molecules Removal efficiency (%)
Min Max Average
Codeine 31.6 (165) 96.0 (115) 71.9
Cyclophosphamide 23.5 (171) 88.9 (115) 59.5
Ifosfamide 21.9 (98) 92.9 (115) 49.3
Sulfamethoxazole 27.0 (128) 99.7 (115) 75.0
Values are in %.
The date corresponding to the minimal or maximal removal is written in blankets.
The negative removals were not taken into account as it results of a membrane re-
placement.
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that a growth can occur whenever possible. The ideal conditions de-
termined would include (i) the absence of surfactants in HWW. (ii) A C/
N ratio of HWW less than 30, which is the critical value as a decrease in
the COD removal occurred systematically beyond. (iii) The application
of a F/M in COD relatively high, probably higher than
0.20 kgCOD kgVSS−1.d−1 seems necessary. The inhibition exerted by
HWW would be selective for independent of the applied F/M. A strong
F/M would allow not impacted bacterial species to assimilate the sub-
strate easily biodegradable of HWW to offset or exceed the losses on
sensitive species. Despite the complexity of HWW, purification yields
above 90% on COD and ammonium have been reached gradually,
which demonstrates that inhibition is not irreversible. The application
of a strong F/M gave higher purification yields. The biggest substrate
quantity available easily biodegradable could have helped the biomass
to compensate for the losses induced by the HWW toxicity but also to
degrade a part of the recalcitrant compounds via co-metabolism. The
denitrification reaction seems however inhibited permanently. The
origin of the malfunction seems to come from surfactants used in large
amounts in hospital services. In terms of performance, 5-FU was
eliminated almost systematically over 90%. The molecule can easily be
removed as confirmed by sludge performances of the WWTP. The re-
moval of four other drugs experienced a lot of fluctuations due to HWW
effects on the biomass and by their retention by the membrane and it’s
fouling, distorting the actual concentrations upstream of the membrane.
Removals in the sMBRe supernatant show that SM and CD can be sig-
nificantly eliminated biologically, respectively to 79 and 95% while
eliminating IF and CP in the reactor appears more moderate since it
does not exceed 40%. The high membrane fouling reaches an apparent
removal above or equal to 89% of the whole selected drugs. This phe-
nomenon had never been outlined in the literature apart from the ob-
vious studies including membranes with cutoff below the studied
100 kDa hollow fibers. Activated sludge developed in the MBR pilot
showed great abilities to adapt to drugs contained in HWW, especially
for anticancer CP and IF. This finding is supported by the conservation
of the purification capacities of the biomass in the presence of drug
cocktail, by acquiring a pronounced antibiotic resistance and especially
by the creation of biotransformation capacities on selected drugs.
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